(Q30874943)

27 June 2017

Creating and engineering human antibodies for immunotherapy (English)

1 reference

27 June 2017

1 reference

1 reference

Hoogenboom HR

1

1 reference

27 June 2017

Henderikx P

series ordinal

2

1 reference

27 June 2017

de Haard H

series ordinal

3

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

27 June 2017

27

1 reference

Advanced Drug Delivery Reviews

inferred from page(s)

published in

1 reference

27 June 2017

31

1 reference

27 June 2017

5-31

1 reference

27 June 2017

1-2

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Human monoclonal antibody production. Current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Production of functional chimaeric mouse/human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

In vitro antibodies: strategies for production and application

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Strategies for expressing human antibody repertoires in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Clinical issues in antibody design.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Escherichia coli secretion of an active chimeric antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Antibody engineering: advances from the use of Escherichia coli expression systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A comparison of strategies to stabilize immunoglobulin Fv-fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A designed metal-binding protein with a novel fold

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Making antibody fragments using phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A recombinant immunotoxin containing a disulfide-stabilized Fv fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Hybridoma fusion cell lines contain an aberrant kappa transcript

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Surface presentation of protein epitopes using bacteriophage expression systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A new filamentous phage cloning vector: fd-tet

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Hormone phage: an enrichment method for variant proteins with altered binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Fab assembly and enrichment in a monovalent phage display system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Inclusion of an upstream transcriptional terminator in phage display vectors abolishes background expression of toxic fusions with coat protein g3p.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selecting high-affinity binding proteins by monovalent phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Efficient epitope mapping by bacteriophage lambda surface display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Surface display of proteins on bacteriophage lambda heads

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Display of peptides and proteins on the surface of bacteriophage lambda

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Lambda foo: a lambda phage vector for the expression of foreign proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Immobilizing proteins on the surface of yeast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

By-passing immunization: building high affinity human antibodies by chain shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Designing and optimizing library selection strategies for generating high-affinity antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection of binders from phage displayed antibody libraries using the BIAcore biosensor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Directing phage selections towards specific epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Use of living columns to select specific phage antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection of phage antibodies by binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Protease inhibitor display M13 phage: selection of high-affinity neutrophil elastase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Human anti-self antibodies with high specificity from phage display libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Retrieval of human antibodies from phage-display libraries using enzymatic cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A model phage display subtraction method with potential for analysis of differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A mathematical model for biopanning (affinity selection) using peptide libraries on filamentous phage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Combinatorial antibodies against human malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Iterative optimization of high-affinity proteases inhibitors using phage display. 1. Plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Co-selection of cognate antibody-antigen pairs by selectively-infective phages.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Clonal selection and amplification of phage displayed antibodies by linking antigen recognition and phage replication

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Direct interaction rescue, a novel filamentous phage technique to study protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Use of antibody fragments (Fv) in immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Genetic Approach to Facilitate Purification of Recombinant Proteins with a Novel Metal Chelate Adsorbent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Phage diabody repertoires for selection of large numbers of bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Targeting vectors for intracellular immunisation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Chemical selection for catalysis in combinatorial antibody libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Direct selection for a catalytic mechanism from combinatorial antibody libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Phage libraries for generation of clinically useful antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Generating a phage display antibody library against an identified neuron

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A novel and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Repertoire cloning of a human IgG inhibitor of alpha IIB beta 3 function. The OG idiotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Cell selection strategies for making antibodies from variable gene libraries: trapping the memory pool

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Human autoimmune anti-proteinase 3 scFv from a phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection and evolution of high-affinity human anti-viral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Anatomy of the antibody molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Canonical structures for the hypervariable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Domain libraries: synthetic diversity for de novo design of antibody V-regions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Immune network theory

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

An in vitro polysome display system for identifying ligands from very large peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Functional antibody production using cell-free translation: effects of protein disulfide isomerase and chaperones.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Engineering bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Kinetic and affinity limits on antibodies produced during immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Construction and evolution of antibody-phage libraries by DNA shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Identification of functional and structural amino-acid residues by parsimonious mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

The Imprint of Somatic Hypermutation on the Repertoire of Human Germline V Genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Coupling protein design and in vitro selection strategies: improving specificity and affinity of a designed beta-protein IL-6 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Light chain shuffling of a high affinity antibody results in a drift in epitope recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Mix and match: building manifold binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Tetravalent miniantibodies with high avidity assembling in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Design and production of novel tetravalent bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Applications of monoclonal antibodies in clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

T-cell-targeted immunofusion proteins from E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Recombinant Toxins for Cancer Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Humanization of immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Immunotherapy of human colon cancer by antibody-targeted superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

Bispecific antibodies: the new magic bullets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900091-4

7 January 2021

10.1016/S0169-409X(97)00091-4

Identifiers

DOI

1 reference

27 June 2017

1 reference